4//SEC Filing
Palasis Maria 4
Accession 0001193125-25-230193
CIK 0001327273other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:15 PM ET
Size
5.9 KB
Accession
0001193125-25-230193
Insider Transaction Report
Form 4
Palasis Maria
DirectorPresident & CEO
Transactions
- Award
Employee Stock Option (right to buy)
2025-10-01+3,667→ 7,333 totalExercise: $303.50Exp: 2034-03-20→ Common Stock (3,667 underlying)
Footnotes (1)
- [F1]On March 21, 2024, the Reporting Person was granted a performance stock option ("PSO") for an aggregate of up to 11,000 shares of common stock (or 550,000 shares on a pre-split basis) under the Issuer's 2020 Incentive Award Plan (the "Agreement"). Under the terms of the Agreement, the underlying PSO shares will vest upon certain milestone events. On October 1, 2025, the Issuer determined that Milestone 2 of the PSO was achieved, resulting in 3,667 PSOs being earned. The earned PSOs will vest on January 31, 2028.
Documents
Issuer
Lyra Therapeutics, Inc.
CIK 0001327273
Entity typeother
Related Parties
1- filerCIK 0001810701
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:15 PM ET
- Size
- 5.9 KB